EU/India drug seizure row appears settled, but Indian firms wary of ACTA
This article was originally published in Scrip
Executive Summary
India is said to have reached an understanding with the EU on the controversial issue of seizures of transiting Indian consignments of generic medicines at EU ports over alleged violations of intellectual property rights (IPRs), although the domestic industry in India is giving only a guarded thumbs up as of yet.